Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study

J Jae Ryong Song J Jehwi Jeon S Seung Chul Baek A Ashish Sharma M Min Sagong C Christopher Seungkyu Lee S Se Joon Woo C Carl Regillo A Arshad M. Khanani D David Eichenbaum B Baruch D. Kuppermann A Anat Loewenstein F Francesco Bandello L Luke Nicholson C Clara Vazquez-Alfageme D David Boyer N Nilesh Kumar N Nikulaa Parachuri A Alay Banker K Kourous A. Rezaei P Peter K. Kaiser F Frank G. Holz (Department of Ophthalmology, University of Bonn, Bonn, Germany) S Sobha Sivaprasad T Taku Wakabayashi (Graduate School of Science) G Giuseppe Querques � Şengül Özdek K Kodjikian Laurent A Alper Bilgic P Paolo Lanzetta C Caroline R. Baumal N Nancy Holekemp T Taiji Sakamoto A Adnan Tufail N Nicolas Yannuzzi G Giulia Corradetti J Jay Sheth C Chitaranjan Mishra D Debdulal Chakraborty A Aleksandra Rachitskaya T Tunde Peto M Maximilian W. M. Wintergerst V Valentina Sarao B Barbara Parolini K Khalil Ghasemi Falavarjani Q Quan Dong Nguyen D Diana V. Do P Pearse A. Keane T Tarek Hassan (Boston University and National Bureau of Economic Research ,) J Jayanth Sridhar D Dilraj S. Grewal F Francesc March M Martin Spitzer M Martin S. Zinkernagel T Tomoko Ueda-Consolvo M Masaaki Ishida T Tomoko Nakamura S Shuichiro Yanagisawa K Kotaro Tsuboi A Atsushi Hayashi J Judy Kim